NOVAVAX INC revenue breakdown overview

NOVAVAX INC revenue for the last year amounted to 658.95 M EUR, the most of which — 183.74 M EUR — came from its highest performing source at the moment, Innovative Vaccines, the year earlier bringing 481.44 M EUR. The greatest contribution to the revenue figure was made by Europe — last year it brought NOVAVAX INC 90.10 M EUR, and the year before that — 243.14 M EUR.